C’ville Company Uses Genetics and Big Data to Find Better Medical Treatments


  Amrie Grammer is co-founder of AMPEL, a company that combines genetics and big data to discover new medical treatments. (Credit Amrie Grammer)

Getting approval for new drugs takes years and costs companies millions of dollars.  What’s more, clinical trials sometimes fail, leaving firms with nothing to show.

Now, however, a Virginia company is taking a different approach – looking at drugs that already have FDA approval to see what other conditions they might treat.

Sandy Hausman explains.

  1. Leave a comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: